Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

15.05
+0.64004.44%
Post-market: 15.050.00000.00%16:25 EDT
Volume:64.82K
Turnover:979.19K
Market Cap:383.69M
PE:-7.77
High:15.69
Open:14.42
Low:14.42
Close:14.41
Loading ...
Oct 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 01, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 23, 2020

Major Issues Report

8-K - Current report
Sep 23, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 19, 2020

Major Issues Report

8-K/A [Amend] - Current report
Aug 18, 2020

Major Issues Report

8-K - Current report
Aug 14, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 05, 2020

Major Issues Report

8-K - Current report
Apr 15, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 03, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 31, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 30, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 30, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 26, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 18, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 26, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 07, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]